A study by Teng et al. on advanced malignant melanomas showed that tumor microenvironment (TME) can be classified based on tumor infiltrating lymphocytes (TILs) and PD-L1 expression: PD-L1+ TIL+ group of tumors favorably responded to immune checkpoint blockade [8]. The gene discussed is CD274; the disease is melanoma.